Democratizing mRNA, one raw material at a time.
Areterna is a biotech company with a mission to democratize mRNA vaccines and therapeutics by supplying low-cost, GMP-grade raw materials to customers in the US and Europe.
Founded to serve, built to supply.
Areterna LLC was founded in 2023 as a wholly owned subsidiary of Synthgene Biotechnology Co., Ltd. to serve customers in the US and Europe.
To help customers accelerate their mRNA drug development, we provide comprehensive services — from sequence design and IVT process development to analytical testing and LNP formulation — alongside a growing catalog of cap analogs, NTPs, modified nucleotides, enzymes and IVT kits.
Synthgene Biotech, our parent company, provides materials and services to support mRNA and oligonucleotide manufacturing. Founded in 2018 by a group of passionate nucleic acid chemists, its mission is to debottleneck the raw material supply and develop innovative solutions to support customers in the industry.
Three ways we support your program
mRNA raw materials
cGMP manufacture of NTPs, modified NTPs and cap analogs — with Drug Master Files filed with the FDA for GMP raw materials.
Development services
Analytical development, mRNA-related impurity standards and detection kits, LNP screening, IVT process development and IVT kits for mRNA research.
Oligo synthesis materials
High-quality phosphoramidites for solid-phase DNA and RNA synthesis, supporting cGMP oligo manufacturing.
A quality system you can file against.
The company maintains a robust quality system supporting cGMP manufacturing of mRNA raw materials — so your supply chain stands up to regulatory scrutiny from research through commercial stage.
-
ISO 9001 certificationRobust, audited quality management system
-
FDA Drug Master FilesDMFs filed for GMP raw materials — NTPs, modified NTPs, cap analogs
-
Independent IP, license-freeFrom R&D through commercial stage — no royalty stacking
-
AI-assisted discovery platform200+ R&D scientists continuing to bring new products to market
From a group of chemists to two continents
Synthgene founded
A group of passionate nucleic acid chemists sets out to debottleneck the raw material supply.
Areterna established
Wholly owned subsidiary launched in Maryland to serve customers in the US and Europe.
Biomay partnership
Strategic partnership to jointly serve mRNA CDMO customers in Europe and North America.
Expanding the catalog
AI-assisted discovery keeps new cap analogs, kits and standards coming to market.
Let's accelerate your mRNA program.
Talk to our team about raw materials, GMP supply or development services — or explore careers as we build our North American team.
Contact UsHeadquarters
12358 Parklawn Drive, Suite 279, N Bethesda, MD 20852